UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour
about
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human gliomaGlioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.Immunotherapy of malignant brain tumors.Dendritic cell-based immunotherapy for malignant gliomas.Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.Targeted therapies for malignant glioma: progress and potential.Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.Cellular immunotherapy for high-grade glioma.Cancer immunoediting in malignant glioma.Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against CancerNanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism.Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).
P2860
Q24615166-49433DD1-E765-4817-BCA5-1F635CFD6A35Q33999299-FA23183A-B02E-41FE-8BE5-45AF4C4D7F14Q36162929-D147A522-3493-43D1-984B-6E18BBEB57EEQ36198607-8F83F09A-0900-451E-AF14-8D44E7561710Q36610286-94EC3C30-6038-4085-9B17-A304B7BAD0C2Q37159549-C6353216-1804-45FA-BD97-92B097C315A1Q37580419-0CCC9F0C-22DB-4FD8-B741-E210E0FD95C1Q37851972-DE24531A-993B-43D9-8C16-90CC834CD661Q37986999-EABAA0F5-CD76-49C1-9EF2-C04962BD2CFAQ38544783-9D2B6EE8-E1C5-42A5-A62D-9B2ECB0BBDD7Q41639218-0CB0853B-2AD9-4C75-87B3-5DFF286BD6E7Q52683991-09190A9B-809B-4D25-B78A-75CE7E0CDEB6
P2860
UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
UDP-Gal: betaGlcNAc beta1, 3-g ...... rom patients with brain tumour
@ast
UDP-Gal: betaGlcNAc beta1, 3-g ...... rom patients with brain tumour
@en
type
label
UDP-Gal: betaGlcNAc beta1, 3-g ...... rom patients with brain tumour
@ast
UDP-Gal: betaGlcNAc beta1, 3-g ...... rom patients with brain tumour
@en
prefLabel
UDP-Gal: betaGlcNAc beta1, 3-g ...... rom patients with brain tumour
@ast
UDP-Gal: betaGlcNAc beta1, 3-g ...... rom patients with brain tumour
@en
P2093
P2860
P356
P1476
UDP-Gal: betaGlcNAc beta1, 3-g ...... rom patients with brain tumour
@en
P2093
S Shichijo
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600593
P407
P577
2002-10-01T00:00:00Z